Profile data is unavailable for this security.
About the company
Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.
- Revenue in INR (TTM)1.72bn
- Net income in INR113.47m
- Incorporated1994
- Employees213.00
- LocationMedico Remedies Ltd1105/1106, 11Th Floor, Hubtown Solaris,Andheri (East), N.S.Phadke MargTHANE 401404IndiaIND
- Phone+91 8 046047706
- Fax+91 2 226281059
- Websitehttps://www.medicoremediesindia.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lyka Labs Ltd | 1.34bn | -6.54m | 2.51bn | 499.00 | -- | -- | 33.45 | 1.87 | -0.1801 | -0.1801 | 37.32 | -- | -- | -- | -- | 2,682,217.00 | -- | 2.35 | -- | 3.44 | 60.96 | 61.79 | -0.2546 | 3.29 | -- | -0.3263 | -- | -- | 24.55 | 17.63 | 421.84 | -- | 70.13 | -- |
| Nectar Lifesciences Ltd | 7.17bn | -1.26bn | 2.61bn | 1.79k | -- | -- | -- | 0.3646 | -5.64 | -15.87 | 32.08 | -- | -- | -- | -- | 4,014,993.00 | -- | -1.57 | -- | -2.87 | -7.31 | 15.34 | -17.57 | -2.24 | -- | -3.77 | -- | -- | -0.838 | -6.73 | -2,375.90 | -- | -4.37 | -- |
| Bafna Pharmaceuticals Ltd | 1.42bn | 87.72m | 2.93bn | 406.00 | 33.40 | 3.21 | 21.71 | 2.06 | 3.71 | 3.71 | 60.16 | 38.56 | 0.9655 | 3.27 | 4.30 | 3,505,907.00 | 5.95 | 5.99 | 8.39 | 8.81 | 32.77 | 34.24 | 6.16 | 5.94 | 1.03 | 3.35 | 0.2621 | -- | -4.31 | 28.01 | -43.49 | -- | 72.56 | -- |
| ZIM Laboratories Ltd | 3.78bn | 69.83m | 3.65bn | 577.00 | 51.92 | -- | 13.43 | 0.965 | 1.44 | 1.44 | 78.03 | -- | -- | -- | -- | 6,548,695.00 | -- | 4.08 | -- | 6.64 | 55.93 | 48.54 | 1.85 | 4.24 | -- | 1.35 | -- | 0.00 | 3.16 | 6.42 | -29.46 | 29.84 | 17.10 | -- |
| Haleos Labs Ltd | 3.38bn | 186.98m | 3.88bn | 592.00 | 20.72 | 1.88 | 11.26 | 1.15 | 61.85 | 61.85 | 1,116.73 | 682.76 | 0.8598 | 2.95 | 5.10 | 5,702,460.00 | 4.88 | 4.26 | 8.16 | 7.05 | 37.95 | 32.35 | 5.67 | 4.76 | 0.5517 | 3.95 | 0.2388 | 2.85 | 12.67 | 5.74 | 121.15 | 14.58 | -8.05 | -- |
| Medico Remedies Ltd | 1.72bn | 113.47m | 3.94bn | 213.00 | 34.40 | 5.89 | 27.41 | 2.30 | 1.38 | 1.38 | 20.86 | 8.06 | 1.45 | 4.24 | 3.16 | 8,060,085.00 | 9.60 | 7.65 | 18.41 | 14.77 | 27.88 | 24.48 | 6.61 | 4.87 | 1.03 | 9.55 | 0.1578 | -- | 4.15 | 11.23 | 21.74 | 44.00 | -0.8645 | -- |
| Amanta Healthcare Ltd | -100.00bn | -100.00bn | 4.22bn | 506.00 | -- | 2.00 | -- | -- | -- | -- | -- | 54.26 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.34 | -- | 0.4687 | -- | -2.01 | -- | 189.02 | -- | -- | -- |
| Albert David Ltd | 3.23bn | 96.12m | 4.24bn | 1.81k | 44.15 | -- | 22.97 | 1.32 | 16.84 | 16.84 | 565.37 | -- | -- | -- | -- | 1,787,412.00 | -- | 8.95 | -- | 11.63 | 64.95 | 59.69 | 2.98 | 11.56 | -- | -4.67 | -- | 13.64 | -4.61 | 1.51 | -77.19 | -2.14 | -0.7463 | -6.51 |
| Medicamen Biotech Ltd | 1.65bn | 101.58m | 4.66bn | 376.00 | 43.85 | 1.59 | 31.42 | 2.83 | 7.84 | 7.84 | 121.55 | 216.61 | 0.5033 | 1.27 | 2.46 | 4,387,495.00 | 2.59 | 4.69 | 3.39 | 6.63 | 50.32 | 38.01 | 5.15 | 8.13 | 1.81 | 2.40 | 0.1231 | 10.57 | -9.35 | 5.31 | -34.97 | -11.77 | -35.60 | 14.87 |
